Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy

NCT02990936 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire UCLouvain Namur as lead sponsor.

NCT NCT02990936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02990936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy
Lead sponsor
Centre Hospitalier Universitaire UCLouvain Namur
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2019
Completion date
November 30, 2026
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, tumor growth